Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.
Patricia Del CerroCarolina AlquézarFernando BartoloméPedro González-NaranjoConcepción PérezEva CarroJuan A PáezNuria E CampilloÁngeles Martín-RequeroPublished in: CNS drugs (2019)
Our results suggest that the activation of CB2 receptors could be considered a useful therapeutic approach for Alzheimer's disease.
Keyphrases